Randomized trials on radioactive iodine ablation of thyroid remnants for thyroid carcinoma—a critique
- 1 June 1999
- journal article
- review article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 44 (3) , 493-495
- https://doi.org/10.1016/s0360-3016(98)00553-7
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Follow-up of Patients with Thyroid CarcinomaNew England Journal of Medicine, 1997
- Thyroid Remnant 131I Ablation for Papillary and Follicular Thyroid CarcinomaThyroid®, 1997
- Author replyCancer, 1997
- Prospective randomized clinical trial to evaluate the optimal dose of131I for remnant ablation in patients with differentiated thyroid carcinomaCancer, 1997
- Prospective randomized clinical trial to evaluate the optimal dose of131I for remnant ablation in patients with differentiated thyroid carcinomaCancer, 1996
- Subverting Randomization in Controlled TrialsJAMA, 1995
- High or low dose radioiodine ablation of thyroid remnants?European Journal of Nuclear Medicine and Molecular Imaging, 1987